Category:Stuart Milstein of Arlington MA (US)

Stuart Milstein of Arlington MA (US)

Executive Summary

Stuart Milstein of Arlington MA (US) is an inventor who has filed 3 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (3 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (3 patents), Spatial arrangement of the modifications (2 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (3 patents). Their most frequent collaborators include (3 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

File:Stuart Milstein of Arlington MA (US) Monthly Patent Applications.png

Technology Areas

File:Stuart Milstein of Arlington MA (US) Top Technology Areas.png

List of Technology Areas

• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 3 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2310/343 (Spatial arrangement of the modifications): 2 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2310/315 (of the backbone): 2 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/51 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P1/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P1/18 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P9/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P9/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P13/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P15/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
• C12N2310/321 (2'-O-R Modification): 1 patents
• C12N2310/322 (2'-R Modification): 1 patents
• C12N2310/335 (of the base): 1 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:Stuart Milstein of Arlington MA (US) Top Companies.png

List of Companies

• Alnylam Pharmaceuticals, Inc.: 3 patents

Collaborators

• Martin A. Maier of Belmont MA (US) (3 collaborations)
• Donald Foster of Attleboro MA (US) (2 collaborations)
• Klaus Charisse of Acton MA (US) (2 collaborations)
• Gregory Hinkle of Plymouth MA (US) (2 collaborations)
• Satyanarayana Kuchimanchi of Acton MA (US) (2 collaborations)
• Muthiah Manoharan of Weston MA (US) (2 collaborations)
• Kevin Fitzgerald of Brookline MA (US) (2 collaborations)
• Brian Bettencourt of Groton MA (US) (1 collaborations)
• Mark K. Schlegel of Boston MA (US) (1 collaborations)
• Maja Janas of Cambridge MA (US) (1 collaborations)
• Vasant R. Jadhav of Sharon MA (US) (1 collaborations)
• Kallanthottathil G. Rajeev of Wayland MA (US) (1 collaborations)
• Alexander V. Kel'in of Swampscott MA (US) (1 collaborations)
• Jayaprakash K. Nair of Cambridge MA (US) (1 collaborations)
• Shigeo Matsuda of Cambridge MA (US) (1 collaborations)
• Muthusamy Jayaraman of Cambridge MA (US) (1 collaborations)
• Alfica Sehgal of Medford MA (US) (1 collaborations)
• Christopher Brown of Cambridge MA (US) (1 collaborations)
• William Querbes of Boston MA (US) (1 collaborations)
• James Butler of Lynnfield MA (US) (1 collaborations)
• Stephanie Williams of Littleton MA (US) (1 collaborations)
• Abigail Liebow of Somerville MA (US) (1 collaborations)